{"database":"GEO","file_versions":[{"headers":{"Content-Type":["application/json"]},"body":{"files":{"Txt":["ftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE302nnn/GSE302763/suppl/filelist.txt","ftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE302nnn/GSE302763/suppl/GSE302763_GPL31165_Gene_Expression.txt.gz"],"Raw":["ftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE302nnn/GSE302763/suppl/GSE302763_RAW.tar"],"Other":["ftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE302nnn/GSE302763/"]},"type":"primary"},"statusCode":"OK","statusCodeValue":200}],"scores":null,"additional":{"omics_type":["Transcriptomics"],"species":["Mus musculus"],"gds_type":["Expression profiling by array"],"full_dataset_link":["https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE302763"],"repository":["GEO"],"entry_type":["GSE"],"additional_accession":[]},"is_claimable":false,"name":"Integration of tumor-specific dendritic cell and antibody therapy within tumor drives innate and adaptive anti-cancer immunity [Myeloid_Innate_Immunity_NanoString]","description":"Comparison of gene expression profiles of HER2+ murine mammary carcinoma treated with HER2 DC1, anti-Sema4D, and combination of both HER2 DC1 and anti-Sema4D therapy","dates":{"publication":"2026/02/02"},"accession":"GSE302763","cross_references":{"GSM":["GSM9110970","GSM9110960","GSM9110971","GSM9110963","GSM9110974","GSM9110975","GSM9110964","GSM9110972","GSM9110961","GSM9110973","GSM9110962","GSM9110967","GSM9110968","GSM9110965","GSM9110966","GSM9110958","GSM9110969","GSM9110959"],"GPL":["31165"],"GSE":["302763"],"taxon":["Mus musculus"]}}